+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Medical/Diagnostic Imaging Market By Product Type, By Application: Global Opportunity Analysis and Industry Forecast, 2020-2030

  • PDF Icon

    Report

  • 160 Pages
  • March 2022
  • Region: Global
  • Allied Market Research
  • ID: 5640598
The global medical/diagnostic imaging market was valued at $38,514.8 million in 2020, and is projected to reach $68,826.6 million by 2030, registering a CAGR of 5.8% from 2021 to 2030.

Medical/diagnostic imaging is the use of electromagnetic radiation and certain other technologies to produce images of internal structures of the body for the purpose of accurate diagnosis. Diagnostic imaging is roughly equivalent to radiology, the branch of medicine that uses radiation to diagnose and treat diseases.

The increase in prevalence of chronic diseases such as cancer, cardiovascular disease globally drives the growth of medical/diagnostic imaging market. For instance, according to World Health Organization (WHO), it was reported that cancer is one of the leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, which is nearly one in six deaths. In addition, increase in healthcare expenditure and rise in demand for advanced imaging for accurate diagnosis propels the growth of medical/diagnostic imaging market. The increase in R&D activities to use the advanced technology in diagnosis of disease contributes in the growth of market. Furthermore, rise in number of hospitals and well-developed healthcare infrastructure contributes in market growth.

In addition, advancement in technology in medical imaging system and surge in product launch contribute to the growth of the medical/diagnostic imaging market. However, the high cost of medical imaging technology is expected to limit the growth of market.

The medical/diagnostic imaging market is segmented on the basis of product type, application, and region. By product type, the market is mainly categorized into MRI systems, Ultrasound imaging systems, X-ray imaging systems, CT Scanners, Nuclear imaging systems, and mammography systems. MRI systems segment is further classified into MRI architecture and MRI field strength. MRI architecture is further bifurcated into closed MRI systems and open MRI systems. MRI field strength is categorized by low to mid field systems, high field systems, very high field systems, and field systems. Ultrasound imaging systems is divided into 2D imaging systems, 3D & 4D imaging systems, Doppler imaging, high-intensity focused ultrasound (HIFU), and Extracorporeal Shock Wave Lithotripsy (ESWL). X-ray imaging systems are further divided into probability based x-ray imaging systems and technology based x-ray imaging systems. Portability based X-Ray imaging systems is categorized into stationary devices and portable devices. Technology based X-Ray imaging systems is further divided into digital imaging and analog imaging. CT scanners segment is fragmented into high end slice, mid end slice and low end slice. Nuclear imaging systems segment is further categorized into PET and SPECT. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include Canon Inc. (Canon Medical Systems USA, Inc.), Carestream Health, Inc., Esaote SpA, General Electric Company (GE Healthcare), Hitachi Ltd. (Hitachi Healthcare America Corporation), Hologic, Inc., Koninklijke Philips N.V., Materialise NV, Planmeca OY and Siemens AG.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical/diagnostic imaging market analysis from 2020 to 2030 to identify the prevailing medical/diagnostic imaging market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the medical/diagnostic imaging market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global medical/diagnostic imaging market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments


By Product Type

  • CT Scanners
  • X ray Imaging Systems
  • MRI Systems
  • Ultrasound Imaging Systems
  • Nuclear Imaging Systems
  • Mammography Systems

By Application

  • Obstetrics and Gynecology Health
  • Orthopedics and Musculoskeletal
  • Neuro and Spine
  • Cardiovascular and Thoracic
  • General Imaging
  • Breast Health
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Latin America
  • Middle East
  • Africa
Frequently Asked Questions about the Global Medical/Diagnostic Imaging Market

What is the estimated value of the Global Medical/Diagnostic Imaging Market?

The Global Medical/Diagnostic Imaging Market was estimated to be valued at $38514.8 million in 2020.

What is the growth rate of the Global Medical/Diagnostic Imaging Market?

The growth rate of the Global Medical/Diagnostic Imaging Market is 6.0%, with an estimated value of $68826.6 million by 2030.

What is the forecasted size of the Global Medical/Diagnostic Imaging Market?

The Global Medical/Diagnostic Imaging Market is estimated to be worth $68826.6 million by 2030.

Who are the key companies in the Global Medical/Diagnostic Imaging Market?

Key companies in the Global Medical/Diagnostic Imaging Market include Canon Inc. (Canon Medical Systems USA Inc.), Carestream Health Inc., Esaote SpA, General Electric Company (GE Healthcare), Hitachi Ltd. (Hitachi Healthcare America Corporation), Hologic Inc., Koninklijke Philips N.V., Materialise NV and Siemens AG.

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: MEDICAL/DIAGNOSTIC IMAGING MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 CT Scanners
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 X ray Imaging Systems
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 MRI Systems
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Ultrasound Imaging Systems
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Nuclear Imaging Systems
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Mammography Systems
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
CHAPTER 5: MEDICAL/DIAGNOSTIC IMAGING MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Obstetrics and Gynecology Health
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Orthopedics and Musculoskeletal
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Neuro and Spine
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Cardiovascular and Thoracic
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 General Imaging
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
5.7 Breast Health
5.7.1 Key market trends, growth factors and opportunities
5.7.2 Market size and forecast, by region
5.7.3 Market analysis by country
5.8 Others
5.8.1 Key market trends, growth factors and opportunities
5.8.2 Market size and forecast, by region
5.8.3 Market analysis by country
CHAPTER 6: MEDICAL/DIAGNOSTIC IMAGING MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Product Type
6.2.3 North America Market size and forecast, by Application
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Product Type
6.2.4.1.2 Market size and forecast, by Application
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Product Type
6.2.4.2.2 Market size and forecast, by Application
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Product Type
6.2.4.3.2 Market size and forecast, by Application
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Product Type
6.3.3 Europe Market size and forecast, by Application
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Product Type
6.3.4.1.2 Market size and forecast, by Application
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Product Type
6.3.4.2.2 Market size and forecast, by Application
6.3.4.3 United Kingdom
6.3.4.3.1 Market size and forecast, by Product Type
6.3.4.3.2 Market size and forecast, by Application
6.3.4.4 Rest of Europe
6.3.4.4.1 Market size and forecast, by Product Type
6.3.4.4.2 Market size and forecast, by Application
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Product Type
6.4.3 Asia-Pacific Market size and forecast, by Application
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 Japan
6.4.4.1.1 Market size and forecast, by Product Type
6.4.4.1.2 Market size and forecast, by Application
6.4.4.2 China
6.4.4.2.1 Market size and forecast, by Product Type
6.4.4.2.2 Market size and forecast, by Application
6.4.4.3 Australia
6.4.4.3.1 Market size and forecast, by Product Type
6.4.4.3.2 Market size and forecast, by Application
6.4.4.4 India
6.4.4.4.1 Market size and forecast, by Product Type
6.4.4.4.2 Market size and forecast, by Application
6.4.4.5 Rest of Asia-Pacific
6.4.4.5.1 Market size and forecast, by Product Type
6.4.4.5.2 Market size and forecast, by Application
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Product Type
6.5.3 LAMEA Market size and forecast, by Application
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Latin America
6.5.4.1.1 Market size and forecast, by Product Type
6.5.4.1.2 Market size and forecast, by Application
6.5.4.2 Middle East
6.5.4.2.1 Market size and forecast, by Product Type
6.5.4.2.2 Market size and forecast, by Application
6.5.4.3 Africa
6.5.4.3.1 Market size and forecast, by Product Type
6.5.4.3.2 Market size and forecast, by Application
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 CANON INC.
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Carestream Health, Inc
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Esaote SpA
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 General Electric Company
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Hitachi Ltd
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 Hologic, Inc.
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Koninklijke Philips N.V.
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Materialise NV
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 planmeca oy
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Siemens AG
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
LIST OF TABLES
Table 1. Global Medical/Diagnostic Imaging Market, by Product Type, 2020-2030, ($Million)
Table 2. Medical/Diagnostic Imaging Market Revenue, for Ct Scanners, by Region, 2020-2030, ($Million)
Table 3. Medical/Diagnostic Imaging Market Ct Scanners by Country, 2020-2030, ($Million)
Table 4. Medical/Diagnostic Imaging Market Revenue, for X Ray Imaging Systems, by Region, 2020-2030, ($Million)
Table 5. Medical/Diagnostic Imaging Market X Ray Imaging Systems by Country, 2020-2030, ($Million)
Table 6. Medical/Diagnostic Imaging Market Revenue, for Mri Systems, by Region, 2020-2030, ($Million)
Table 7. Medical/Diagnostic Imaging Market Mri Systems by Country, 2020-2030, ($Million)
Table 8. Medical/Diagnostic Imaging Market Revenue, for Ultrasound Imaging Systems, by Region, 2020-2030, ($Million)
Table 9. Medical/Diagnostic Imaging Market Ultrasound Imaging Systems by Country, 2020-2030, ($Million)
Table 10. Medical/Diagnostic Imaging Market Revenue, for Nuclear Imaging Systems, by Region, 2020-2030, ($Million)
Table 11. Medical/Diagnostic Imaging Market Nuclear Imaging Systems by Country, 2020-2030, ($Million)
Table 12. Medical/Diagnostic Imaging Market Revenue, for Mammography Systems, by Region, 2020-2030, ($Million)
Table 13. Medical/Diagnostic Imaging Market Mammography Systems by Country, 2020-2030, ($Million)
Table 14. Global Medical/Diagnostic Imaging Market, by Application, 2020-2030, ($Million)
Table 15. Medical/Diagnostic Imaging Market Revenue, for Obstetrics and Gynecology Health, by Region, 2020-2030, ($Million)
Table 16. Medical/Diagnostic Imaging Market Obstetrics and Gynecology Health by Country, 2020-2030, ($Million)
Table 17. Medical/Diagnostic Imaging Market Revenue, for Orthopedics and Musculoskeletal, by Region, 2020-2030, ($Million)
Table 18. Medical/Diagnostic Imaging Market Orthopedics and Musculoskeletal by Country, 2020-2030, ($Million)
Table 19. Medical/Diagnostic Imaging Market Revenue, for Neuro and Spine, by Region, 2020-2030, ($Million)
Table 20. Medical/Diagnostic Imaging Market Neuro and Spine by Country, 2020-2030, ($Million)
Table 21. Medical/Diagnostic Imaging Market Revenue, for Cardiovascular and Thoracic, by Region, 2020-2030, ($Million)
Table 22. Medical/Diagnostic Imaging Market Cardiovascular and Thoracic by Country, 2020-2030, ($Million)
Table 23. Medical/Diagnostic Imaging Market Revenue, for General Imaging, by Region, 2020-2030, ($Million)
Table 24. Medical/Diagnostic Imaging Market General Imaging by Country, 2020-2030, ($Million)
Table 25. Medical/Diagnostic Imaging Market Revenue, for Breast Health, by Region, 2020-2030, ($Million)
Table 26. Medical/Diagnostic Imaging Market Breast Health by Country, 2020-2030, ($Million)
Table 27. Medical/Diagnostic Imaging Market Revenue, for Others, by Region, 2020-2030, ($Million)
Table 28. Medical/Diagnostic Imaging Market Others by Country, 2020-2030, ($Million)
Table 29. Medical/Diagnostic Imaging Market, by Region, 2020-2030, ($Million)
Table 30. North America Medical/Diagnostic Imaging Market, by Product Type, 2020-2030, ($Million)
Table 31. North America Medical/Diagnostic Imaging Market, by Application, 2020-2030, ($Million)
Table 32. North America Medical/Diagnostic Imaging Market, by Country, 2020-2030, ($Million)
Table 33. U.S. Medical/Diagnostic Imaging Market by Product Type 2020-2030, ($Million)
Table 34. U.S. Medical/Diagnostic Imaging Market by Application 2020-2030, ($Million)
Table 35. Canada Medical/Diagnostic Imaging Market by Product Type 2020-2030, ($Million)
Table 36. Canada Medical/Diagnostic Imaging Market by Application 2020-2030, ($Million)
Table 37. Mexico Medical/Diagnostic Imaging Market by Product Type 2020-2030, ($Million)
Table 38. Mexico Medical/Diagnostic Imaging Market by Application 2020-2030, ($Million)
Table 39. Europe Medical/Diagnostic Imaging Market, by Product Type, 2020-2030, ($Million)
Table 40. Europe Medical/Diagnostic Imaging Market, by Application, 2020-2030, ($Million)
Table 41. Europe Medical/Diagnostic Imaging Market, by Country, 2020-2030, ($Million)
Table 42. Germany Medical/Diagnostic Imaging Market by Product Type 2020-2030, ($Million)
Table 43. Germany Medical/Diagnostic Imaging Market by Application 2020-2030, ($Million)
Table 44. France Medical/Diagnostic Imaging Market by Product Type 2020-2030, ($Million)
Table 45. France Medical/Diagnostic Imaging Market by Application 2020-2030, ($Million)
Table 46. United Kingdom Medical/Diagnostic Imaging Market by Product Type 2020-2030, ($Million)
Table 47. United Kingdom Medical/Diagnostic Imaging Market by Application 2020-2030, ($Million)
Table 48. Rest of Europe Medical/Diagnostic Imaging Market by Product Type 2020-2030, ($Million)
Table 49. Rest of Europe Medical/Diagnostic Imaging Market by Application 2020-2030, ($Million)
Table 50. Asia-Pacific Medical/Diagnostic Imaging Market, by Product Type, 2020-2030, ($Million)
Table 51. Asia-Pacific Medical/Diagnostic Imaging Market, by Application, 2020-2030, ($Million)
Table 52. Asia-Pacific Medical/Diagnostic Imaging Market, by Country, 2020-2030, ($Million)
Table 53. Japan Medical/Diagnostic Imaging Market by Product Type 2020-2030, ($Million)
Table 54. Japan Medical/Diagnostic Imaging Market by Application 2020-2030, ($Million)
Table 55. China Medical/Diagnostic Imaging Market by Product Type 2020-2030, ($Million)
Table 56. China Medical/Diagnostic Imaging Market by Application 2020-2030, ($Million)
Table 57. Australia Medical/Diagnostic Imaging Market by Product Type 2020-2030, ($Million)
Table 58. Australia Medical/Diagnostic Imaging Market by Application 2020-2030, ($Million)
Table 59. India Medical/Diagnostic Imaging Market by Product Type 2020-2030, ($Million)
Table 60. India Medical/Diagnostic Imaging Market by Application 2020-2030, ($Million)
Table 61. Rest of Asia-Pacific Medical/Diagnostic Imaging Market by Product Type 2020-2030, ($Million)
Table 62. Rest of Asia-Pacific Medical/Diagnostic Imaging Market by Application 2020-2030, ($Million)
Table 63. LAMEA Medical/Diagnostic Imaging Market, by Product Type, 2020-2030, ($Million)
Table 64. LAMEA Medical/Diagnostic Imaging Market, by Application, 2020-2030, ($Million)
Table 65. LAMEA Medical/Diagnostic Imaging Market, by Country, 2020-2030, ($Million)
Table 66. Latin America Medical/Diagnostic Imaging Market by Product Type 2020-2030, ($Million)
Table 67. Latin America Medical/Diagnostic Imaging Market by Application 2020-2030, ($Million)
Table 68. Middle East Medical/Diagnostic Imaging Market by Product Type 2020-2030, ($Million)
Table 69. Middle East Medical/Diagnostic Imaging Market by Application 2020-2030, ($Million)
Table 70. Africa Medical/Diagnostic Imaging Market by Product Type 2020-2030, ($Million)
Table 71. Africa Medical/Diagnostic Imaging Market by Application 2020-2030, ($Million)
Table 72. Canon Inc.: Company Snapshot
Table 73. Canon Inc.: Operating Segments
Table 74. Canon Inc.: Product Portfolio
Table 75. Canon Inc.: Net Sales
Table 76. Canon Inc.: Key Stratergies
Table 77. Carestream Health, Inc: Company Snapshot
Table 78. Carestream Health, Inc: Operating Segments
Table 79. Carestream Health, Inc: Product Portfolio
Table 80. Carestream Health, Inc: Net Sales
Table 81. Carestream Health, Inc: Key Stratergies
Table 82. Esaote Spa: Company Snapshot
Table 83. Esaote Spa: Operating Segments
Table 84. Esaote Spa: Product Portfolio
Table 85. Esaote Spa: Net Sales
Table 86. Esaote Spa: Key Stratergies
Table 87. General Electric Company: Company Snapshot
Table 88. General Electric Company: Operating Segments
Table 89. General Electric Company: Product Portfolio
Table 90. General Electric Company: Net Sales
Table 91. General Electric Company: Key Stratergies
Table 92. Hitachi Ltd: Company Snapshot
Table 93. Hitachi Ltd: Operating Segments
Table 94. Hitachi Ltd: Product Portfolio
Table 95. Hitachi Ltd: Net Sales
Table 96. Hitachi Ltd: Key Stratergies
Table 97. Hologic, Inc.: Company Snapshot
Table 98. Hologic, Inc.: Operating Segments
Table 99. Hologic, Inc.: Product Portfolio
Table 100. Hologic, Inc.: Net Sales
Table 101. Hologic, Inc.: Key Stratergies
Table 102. Koninklijke Philips N.V.: Company Snapshot
Table 103. Koninklijke Philips N.V.: Operating Segments
Table 104. Koninklijke Philips N.V.: Product Portfolio
Table 105. Koninklijke Philips N.V.: Net Sales
Table 106. Koninklijke Philips N.V.: Key Stratergies
Table 107. Materialise Nv: Company Snapshot
Table 108. Materialise Nv: Operating Segments
Table 109. Materialise Nv: Product Portfolio
Table 110. Materialise Nv: Net Sales
Table 111. Materialise Nv: Key Stratergies
Table 112. Planmeca Oy: Company Snapshot
Table 113. Planmeca Oy: Operating Segments
Table 114. Planmeca Oy: Product Portfolio
Table 115. Planmeca Oy: Net Sales
Table 116. Planmeca Oy: Key Stratergies
Table 117. Siemens Ag: Company Snapshot
Table 118. Siemens Ag: Operating Segments
Table 119. Siemens Ag: Product Portfolio
Table 120. Siemens Ag: Net Sales
Table 121. Siemens Ag: Key Stratergies
LIST OF FIGURES
Figure 1. Medical/Diagnostic Imaging Market Segmentation
Figure 2. Medical/Diagnostic Imaging Market, 2020-2030
Figure 3. Medical/Diagnostic Imaging Market, 2020-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Medical/Diagnostic Imaging Market:Drivers, Restraints and Opportunities
Figure 11. Medical/Diagnostic Imaging Market, by Product Type, 2020 (%)
Figure 12. Comparative Share Analysis of CT Scanners Medical/Diagnostic Imaging Market, 2020-2030 (%)
Figure 13. Comparative Share Analysis of X Ray Imaging Systems Medical/Diagnostic Imaging Market, 2020-2030 (%)
Figure 14. Comparative Share Analysis of MRI Systems Medical/Diagnostic Imaging Market, 2020-2030 (%)
Figure 15. Comparative Share Analysis of Ultrasound Imaging Systems Medical/Diagnostic Imaging Market, 2020-2030 (%)
Figure 16. Comparative Share Analysis of Nuclear Imaging Systems Medical/Diagnostic Imaging Market, 2020-2030 (%)
Figure 17. Comparative Share Analysis of Mammography Systems Medical/Diagnostic Imaging Market, 2020-2030 (%)
Figure 18. Medical/Diagnostic Imaging Market, by Application, 2020 (%)
Figure 19. Comparative Share Analysis of Obstetrics and Gynecology Health Medical/Diagnostic Imaging Market, 2020-2030 (%)
Figure 20. Comparative Share Analysis of Orthopedics and Musculoskeletal Medical/Diagnostic Imaging Market, 2020-2030 (%)
Figure 21. Comparative Share Analysis of Neuro and Spine Medical/Diagnostic Imaging Market, 2020-2030 (%)
Figure 22. Comparative Share Analysis of Cardiovascular and Thoracic Medical/Diagnostic Imaging Market, 2020-2030 (%)
Figure 23. Comparative Share Analysis of General Imaging Medical/Diagnostic Imaging Market, 2020-2030 (%)
Figure 24. Comparative Share Analysis of Breast Health Medical/Diagnostic Imaging Market, 2020-2030 (%)
Figure 25. Comparative Share Analysis of Others Medical/Diagnostic Imaging Market, 2020-2030 (%)
Figure 26. Medical/Diagnostic Imaging Market by Region, 2020
Figure 27. U.S. Medical/Diagnostic Imaging Market, 2020-2030 ($Million)
Figure 28. Canada Medical/Diagnostic Imaging Market, 2020-2030 ($Million)
Figure 29. Mexico Medical/Diagnostic Imaging Market, 2020-2030 ($Million)
Figure 30. Germany Medical/Diagnostic Imaging Market, 2020-2030 ($Million)
Figure 31. France Medical/Diagnostic Imaging Market, 2020-2030 ($Million)
Figure 32. United Kingdom Medical/Diagnostic Imaging Market, 2020-2030 ($Million)
Figure 33. Rest of Europe Medical/Diagnostic Imaging Market, 2020-2030 ($Million)
Figure 34. Japan Medical/Diagnostic Imaging Market, 2020-2030 ($Million)
Figure 35. China Medical/Diagnostic Imaging Market, 2020-2030 ($Million)
Figure 36. Australia Medical/Diagnostic Imaging Market, 2020-2030 ($Million)
Figure 37. India Medical/Diagnostic Imaging Market, 2020-2030 ($Million)
Figure 38. Rest of Asia-Pacific Medical/Diagnostic Imaging Market, 2020-2030 ($Million)
Figure 39. Latin America Medical/Diagnostic Imaging Market, 2020-2030 ($Million)
Figure 40. Middle East Medical/Diagnostic Imaging Market, 2020-2030 ($Million)
Figure 41. Africa Medical/Diagnostic Imaging Market, 2020-2030 ($Million)
Figure 42. Top Winning Strategies, by Year
Figure 43. Top Winning Strategies, by Development
Figure 44. Top Winning Strategies, by Company
Figure 45. Product Mapping of Top 10 Players
Figure 46. Competitive Dashboard
Figure 47. Competitive Heatmap of Top 10 Key Players
Figure 48. Canon Inc. Net Sales, ($Million)
Figure 49. Carestream Health, Inc.: Net Sales, ($Million)
Figure 50. Esaote Spa.: Net Sales, ($Million)
Figure 51. General Electric Company.: Net Sales, ($Million)
Figure 52. Hitachi Ltd.: Net Sales, ($Million)
Figure 53. Hologic, Inc. Net Sales, ($Million)
Figure 54. Koninklijke Philips N.V. Net Sales, ($Million)
Figure 55. Materialise Nv.: Net Sales, ($Million)
Figure 56. Planmeca Oy.: Net Sales, ($Million)
Figure 57. Siemens AG.: Net Sales, ($Million)

Executive Summary

According to this report titled, 'Medical/Diagnostic Imaging Market,' the medical imaging market size was valued at $38.5 Billion in 2020, and is estimated to reach $68.8 Billion by 2030, growing at a CAGR of 5.8% from 2021 to 2030. Medical imaging refers to several different technologies that are used to view the human body in order to diagnose, monitor, or treat medical conditions. Each type of technology gives different information about the area of the body being studied or treated, related to possible disease, injury, or the effectiveness of medical treatment.

Factors that drive the growth of the medical/diagnostic imaging market analysis include rise in number of hospitals and increase in prevalence of pneumonia. According to World Health Organization (WHO), in 2019, it was reported that pneumonia killed 740, 180 children under the age of 5, accounting for 14% of all deaths of children under five years old. Furthermore, increase in R&D activity in 3D medical imaging technology contribute in the medical imaging market growth. In addition, the increase in need for medical imaging surge the growth of medical imaging market.

The medical imaging market share is segmented on the basis of product type, application, and region.

By product type, the market is divided into MRI systems, ultrasound imaging systems, X-ray imaging systems, CT scanners, nuclear imaging systems, and mammography systems. The X-ray imaging systems segment dominated the market in 2020, and this trend is expected to continue during the diagnostic imaging market forecast period, owing to advancements in X-ray technology and innovation in technology in medical imaging.

By application, the market is divided into obstetrics/gynecology (ob/gyn) health, orthopedics &musculoskeletal, neuro & spine, cardiovascular & thoracic, general imaging, and breast health. The cardiovascular and thoracicsegment dominated the market in 2020, and this trend is expected to continue during the forecast period due tosurge in prevalence of cardiovascular disease, increase in geriatric population, and rise in sedentary lifestyle.

What is the IMPACT OF COVID-19 Pandemic on the Medical/Diagnostic Imaging Market?

  • The COVID-19 outbreak had a negative impact on the growth of the medical imaging market size as most hospitals were not operating due to COVID-19 and the ongoing lockdowns in many countries. The spread of COVID-19 led to major public health issues. However, a huge number of clinics andhospitals across the globe were restructured to increase the hospital capacity to provide better healthcare facility. In the middle of COVID-19 pandemic, the elective imaging services and ambulatory imaging dropped for a while. Moreover, several policies were updated in radiology department and hospitals regarding technologist, PPE availability, and COVID-19 testing.
  • On the basis of region, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period. North America accounted for a majority of the global medical/diagnostic imaging market share in 2020, and is anticipated to remain dominant during the forecast period due to rise in prevalence of chronic diseases, presence of key players for development of medical imaging outsourcing, and well-established healthcare infrastructure in the region. Asia-Pacific is anticipated to witness lucrative growth owing to increase in the number of hospitals, surge in demand for early diagnosis, upsurge in prevalence of cancer & cardiac disease, and rise in number of geriatric population.

Key Findings of Study

  • On the basis of product type, the X-ray imaging systems segment was the highest contributor to the medical imaging market in 2020.
  • By application, the cardiovascular and thoracic segment was the highest contributor to the medical imaging market in 2020

Companies Mentioned

  • Canon Inc. (Canon Medical Systems USA Inc.)
  • Carestream Health Inc.
  • Esaote SpA
  • General Electric Company (GE Healthcare)
  • Hitachi Ltd. (Hitachi Healthcare America Corporation)
  • Hologic Inc.
  • Koninklijke Philips N.V.
  • Materialise NV
  • Planmeca OY
  • Siemens AG

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...